P. Weeks

发表

How do we manage cardiopulmonary bypass coagulopathy?

P. Loyalka, R. Radovancevic, I. Gregoric, 2014, Transfusion.

Evaluation of bivalirudin hyper- and hypo-ACT responses in the setting of percutaneous coronary intervention.

P. Weeks, J. Díez, Haider Alkhateeb, 2013, The Journal of invasive cardiology.

Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations.

S. Russell, A. Dipchand, M. Flattery, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Improved Ticagrelor Antiplatelet Effect on Discontinuation of Phenytoin

S. Nathan, A. Sieg, P. Weeks, 2014, The Annals of pharmacotherapy.

Implementation of pharmacist‐managed anticoagulation in patients with continuous flow left ventricular assist devices

R. Radovancevic, I. Gregoric, Elaine Chow, 2019, Journal of the American College of Clinical Pharmacy.

Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter?

I. Rajapreyar, A. Sieg, P. Weeks, 2016, Transplantation reviews.

Anticoagulation of Impella with a Bivalirudin Purge Solution

I. Gregoric, B. Kar, P. Weeks, 2020, ASAIO journal.

Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series

P. Weeks, J. Gass, S. Bowman, 2018, The Annals of pharmacotherapy.

Optimizing anticoagulation for patients receiving Impella support

T. Trujillo, Craig J. Beavers, R. Didomenico, 2021, Pharmacotherapy.

Managing New Oral Anticoagulants in the Intensive Care Unit

P. Weeks, J. Gass, 2013, Critical care nursing quarterly.

Comparison of polyspecific versus IgG specific ELISA in predominately cardiac patients with suspected heparin induced thrombocytopenia

Mary F. McGuire, P. Weeks, S. Samuel, 2019, Journal of Thrombosis and Thrombolysis.

A pseudo‐outbreak of disseminated cryptococcal disease after orthotopic heart transplantation

P. Loyalka, I. Gregoric, A. Wanger, 2016, Mycoses.

Angiotensin Inhibition and Gastrointestinal Bleeding Prevention in Patients with Left Ventricular Assist Devices

P. Weeks, 2020 .

Treatment of Multiple Myeloma in a Heart Transplant Recipient

P. Loyalka, Robert Brown, L. Buja, 2017, Progress in transplantation.

The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure

I. Rajapreyar, A. Sieg, P. Weeks, 2016, Heart Failure Reviews.

Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock

I. Rajapreyar, A. Sieg, P. Weeks, 2015, Journal of cardiovascular pharmacology and therapeutics.

Diagnosis of left atrial myxoma at routine coronary angiography in an asymptomatic patient.

P. Weeks, A. Hamer, 1993, Catheterization and cardiovascular diagnosis.

Management of reproductive health after cardiac transplantation

S. Pamboukian, C. Hoopes, J. Tallaj, 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation: A Single-center Experience.

P. Loyalka, I. Gregoric, R. Quintana-Quezada, 2016, Transplantation proceedings.

Bivalirudin for left ventricular assist device thrombosis

R. Radovancevic, I. Gregoric, S. Nathan, 2018, Journal of Thrombosis and Thrombolysis.

Thrombosis in Continuous‐Flow Left Ventricular Assist Devices: Pathophysiology, Prevention, and Pharmacologic Management

D. Jennings, P. Weeks, 2015, Pharmacotherapy.

Evaluation of 4T's scoring system in the identification of heparin-induced thrombocytopenia in patients with mechanical circulatory support.

A. Sieg, P. Weeks, J. Gass, 2017, Thrombosis research.

Carfilzomib-Rituximab Desensitization in Sensitized Heart Transplant Candidates: A Single Center Experience

S. Nathan, I. Rajapreyar, A. Sieg, 2016 .

Risk of Pump Thrombosis and Stroke in Patients with Continuous-Flow Left Ventricular Assist Devices and Gastrointestinal Bleeding.

R. Radovancevic, I. Gregoric, S. Nathan, 2020, Artificial organs.

Evaluation of Vasoactive-Inotropic Score and Survival to Decannulation in Adult Patients on Venoarterial Extracorporeal Life Support: An Observational Cohort Study

R. Radovancevic, I. Gregoric, B. Kar, 2023, ASAIO journal.

An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device.

M. Keebler, L. Tops, I. Rajapreyar, 2024, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.